U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07121868) titled 'Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations' on Aug. 07.
Brief Summary: An open label, randomized, single-dose, two sequence, two-period, crossover study to assess the bioequivalence of Cariprazine in Vocarzine 1.5 mg hard gelatin capsule (Test product) in comparison with Reagila(R) 1.5 mg hard capsules (Reference product) in 30 healthy subjects under fasting conditions
Study Start Date: Aug. 03, 2024
Study Type: INTERVENTIONAL
Condition:
Bioequivalence Study in Healthy Subjects
Intervention:
DRUG: Test Product (Vocarzine)
hard capsule formulation
DRUG: Reference (R) Reagila (R)
hard capsule ...